Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Rambam Health Care Campus.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT01562067
First received: March 21, 2012
Last updated: March 22, 2012
Last verified: March 2011
  Purpose

Cervical tumors are characterized by vascular changes (in terms of quantity, volume and Flows) in the tumor. Due to a good access to the cervix through the vagina, these parameters can be assessed using a three dimensional supersonic. Sonographic characteristics of tumor indices measures before and after oncological treatments may shed light on the patient's prognosis.


Condition Intervention
Cancer
Device: ultrasound examination

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy

Resource links provided by NLM:


Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • Sonographic characteristics of cervical tumors [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    Sonographic characteristics of cervical tumors indices measures before and after oncological treatments may shed light on the patient's prognosis.


Biospecimen Retention:   Samples Without DNA

pap smear


Estimated Enrollment: 40
Study Start Date: March 2012
Estimated Study Completion Date: April 2014
Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: ultrasound examination
    ultrasound and doppler studies to evaluate size and vascularity of tumor during radiotherapy
    Other Name: no other name
Detailed Description:

no editional information. see above

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

women with cervical cancer during radiotherapy

Criteria

Inclusion Criteria:

  • Cervical cancer patients intended to undergo chemotherapy or radiation, or both

Exclusion Criteria:

  • no exclusions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01562067

Locations
Israel
Rambam Medical Center Not yet recruiting
Haifa, Israel, 30196
Contact: amnon amit, md    97248543872 ext 3872    a_amit@rambam.health.gov.il   
Principal Investigator: amnon amit, md         
Sponsors and Collaborators
Rambam Health Care Campus
Investigators
Principal Investigator: amnon amit, md Rambam Health Care Campus
  More Information

No publications provided

Responsible Party: Rambam Health Care Campus
ClinicalTrials.gov Identifier: NCT01562067     History of Changes
Other Study ID Numbers: 125-11CTIL
Study First Received: March 21, 2012
Last Updated: March 22, 2012
Health Authority: Israel: Ministry of Health

Keywords provided by Rambam Health Care Campus:
Cervical tumors,vascular changes,Sonographic characteristics

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female

ClinicalTrials.gov processed this record on July 31, 2014